Article info
A difficult case
Catatonia with GABAA receptor antibodies
- Correspondence to Dr Kiran Samra, Neurology Department, King's College Hospital NHS Foundation Trust, London, UK; kiransamra{at}nhs.net
Citation
Catatonia with GABAA receptor antibodies
Publication history
- Accepted October 23, 2019
- First published November 26, 2019.
Online issue publication
March 17, 2020
Article Versions
- Previous version (26 November 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Delayed LGI1 seropositivity in voltage-gated potassium channel (VGKC)-complex antibody limbic encephalitis
- LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes
- Autoimmune encephalitis in the elderly: who to test and what to test for
- Anti-voltage-gated potassium channel complex antibody–mediated limbic encephalitis: a case report of a 53-year-old man admitted to intensive care psychiatric unit with psychotic mania
- LGI1 antibody encephalitis: acute treatment comparisons and outcome
- Stop testing for autoantibodies to the VGKC-complex: only request LGI1 and CASPR2
- Emergence of new-onset psychotic disorder following recovery from LGI1 antibody-associated limbic encephalitis
- Autoimmune encephalitis: proposed recommendations for symptomatic and long-term management
- Thymoma associated paraneoplastic encephalitis (TAPE), a potential cause of limbic encephalitis
- End of the bed (end of the video) diagnosis